Skip to main content
Dupilumab effective for eosinophilic esophagitis up to 52 weeks
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dupilumab effective for eosinophilic esophagitis up to 52 weeks
User login
Username
Password
Reset your password
Concept
Lead
score
Otolaryngology
1
1
Steroids
0
0.54
Biologic Therapy
0
0.53
Eosinophilic Esophagitis
0
0.99
Esophagitis
0
0.36
Angina Pectoris
0
0.28
Refractory
0
0.27
Remission
0
0.27
Pain Management
0
0.26
Patient Safety
0
0.26
Dermatitis
0
0.22
Chest Pain
0
0.21
Adverse Effects
0
0.18
Diet
0
0.18
Dysphagia
0
0.18
Interleukin
0
0.18
Pain
0
0.18
Proton Pump Inhibitor
0
0.18
Asthma
0
0.13
Nasal Polyp
0
0.13
Abdomen
0
0.09
Atopic Dermatitis
0
0.09
Canada
0
0.09
Eosinophils
0
0.09
Esophagus
0
0.09
Europe
0
0.09
Monoclonal Antibody
0
0.09
New York
0
0.09
North Carolina
0
0.09
Polyp
0
0.09
Receptors
0
0.09
Rhinosinusitis
0
0.09
Thorax
0
0.09
Specialty
Lead
score
Gastroenterology
1
1
Internal Medicine
0
0.9
Pharmacist
0
0.8
Edit Tags